UFPT UFP TECHNOLOGIES INC
FY2025 10-K
UFP TECHNOLOGIES INC (UFPT) filed its fiscal year 2025 10-K annual report with the SEC on Feb 27, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: Contract development and manufacturing of custom single-use, single-patient medical devices and components
- • Emphasis on diverse niche medical segments including minimally invasive surgery, infection prevention, orthopedics, and biopharma packaging
Management Discussion & Analysis
- • Revenue $602.8M, up 19.5% YoY from $504.4M driven by 23.2% medical market growth, acquisitions added $168.3M in 2025 vs $73.1M in 2024
- • Organic sales growth 1.5% for 2025; largest customers Intuitive Surgical SARL 24.3% and Stryker Corporation 21.5% of sales in 2025
Risk Factors
- • Regulatory risk from "One Big Beautiful Bill Act" (OBBBA) enacted July 2025 with immaterial impact on income tax expense but changes to interest and depreciation rules
- • Macroeconomic risk from inflation and bank failures could affect long-term capital access and liquidity despite $91.9M cash from operations in 2025
Financial SummaryXBRL
Revenue
$603M
Net Income
$68M
Gross Margin
28.3%
Operating Margin
15.3%
Net Margin
11.3%
ROE
16.1%
Total Assets
$655M
EPS (Diluted)
$8.75
Operating Cash Flow
$92M
Source: XBRL data from UFP TECHNOLOGIES INC FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on UFP TECHNOLOGIES INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.